First quarter and first-time venture capital deals plunge
This article was originally published in Scrip
Executive Summary
The flight to less-costly investments continued in the first quarter of 2013 when US venture capital commitments declined a relatively meager 12% from fourth quarter 2012 levels across all industries, but plunged 28% for life science companies.